The Mechanism of TNF‐α‐Mediated Accumulation of Phosphorylated Tau Protein and Its Modulation by Propofol in Primary Mouse Hippocampal Neurons: Role of Mitophagy, NLRP3, and p62/Keap1/Nrf2 Pathway
Open Access
- 12 August 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 8661200
Abstract
Background. Neuroinflammation‐induced phosphorylated Tau (p‐Tau) deposition in central nervous system contributes to neurodegenerative disorders. Propofol possesses neuroprotective properties. We investigated its impacts on tumor necrosis factor‐α (TNF‐α)‐mediated p‐Tau deposition in neurons. Methods. Mouse hippocampal neurons were exposed to propofol followed by TNF‐α. Cell viability, p‐Tau, mitophagy, reactive oxygen species (ROS), NOD‐like receptor protein 3 (NLRP3), antioxidant enzymes, and p62/Keap1/Nrf2 pathway were investigated. Results. TNF‐α promoted p‐Tau accumulation in a concentration‐ and time‐dependent manner. TNF‐α (20 ng/mL, 4 h) inhibited mitophagy while increased ROS accumulation and NLRP3 activation. It also induced glycogen synthase kinase‐3β (GSK3β) while inhibited protein phosphatase 2A (PP2A) phosphorylation. All these effects were attenuated by 25 μM propofol. In addition, TNF‐α‐induced p‐Tau accumulation was attenuated by ROS scavenger, NLRP3 inhibitor, GSK3β inhibitor, or PP2A activator. Besides, compared with control neurons, 100 μM propofol decreased p‐Tau accumulation. It also decreased ROS and NLRP3 activation, modulated GSK3β/PP2A phosphorylation, leaving mitophagy unchanged. Further, 100 μM propofol induced p62 expression, reduced Keap1 expression, triggered the nuclear translocation of Nrf2, and upregulated superoxide dismutase (SOD) and heme oxygenase‐1 (HO‐1) expression, which was abolished by p62 knockdown, Keap1 overexpression, or Nrf2 inhibitor. Consistently, the inhibitory effect of 100 μM propofol on ROS and p‐Tau accumulation was mitigated by p62 knockdown, Keap1 overexpression, or Nrf2 inhibitor. Conclusions. In hippocampal neurons, TNF‐α inhibited mitophagy, caused oxidative stress and NLRP3 activation, leading to GSK3β/PP2A‐dependent Tau phosphorylation. Propofol may reduce p‐Tau accumulation by reversing mitophagy and oxidative stress‐related events. Besides, propofol may reduce p‐Tau accumulation by modulating SOD and HO‐1 expression through p62/Keap1/Nrf2 pathway.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (21ZR1414000)
- National Key Research and Development Program of China (2018YFC2002400)
This publication has 59 references indexed in Scilit:
- Role of neuroinflammation in neurodegenerative diseases (Review)Molecular Medicine Reports, 2016
- ROS‐Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion InjuryOxidative Medicine and Cellular Longevity, 2016
- Propofol can Protect Against the Impairment of Learning-memory Induced by Electroconvulsive Shock via Tau Protein Hyperphosphorylation in Depressed RatsChinese Medical Sciences Journal, 2015
- Propofol: an anesthetic possessing neuroprotective effects2015
- Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot studyAnnals of Cardiac Anaesthesia, 2015
- Neuroprotective Effects of Intravenous Anesthetics: A New Critical PerspectiveCurrent Pharmaceutical Design, 2014
- The common inflammatory etiology of depression and cognitive impairment: a therapeutic targetJournal of Neuroinflammation, 2014
- The effects of propofol on mitochondrial dysfunction following focal cerebral ischemia–reperfusion in ratsNeuropharmacology, 2014
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progressionTrends in Immunology, 2008
- Tau pathology in Alzheimer disease and other tauopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005